In a report published Tuesday, Morgan Stanley analyst Thomas Allen upgraded the rating on H&R Block HRB from Equal-Weight to Overweight, and raised the price target from $25.00 to $33.00.
In the report, Morgan Stanley noted, “While HRB has traded off over the past few months on concerns ACA will be delayed or de-funded, we have warmed up to the stock, especially after HRB partnered w/ GoHealth. We've adjusted our ests to reflect our latest thinking on ACA / buybacks, resulting in F15 EPS of $2.20, 15x multiple, $33 PT.”
H&R Block closed on Monday at $26.66.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in